Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Jeno Marton

Gabor Kovacs

Peter Szentmiklosi

Peter S Kormoczy

Istvan Hermecz

Lajos Szabo

Agnes Horvath

Sandor Virag

Jozsef Knoll

Jozsef Szejtli

Zoltan Meszaros

Dezso Korbonits

Gergely Heja

Istvan Stadler

Laszlo Tardos

Tamas Szuts

Lajos Szente

Katalin Marmarosi Nee Kellner

Gabor Horvath

Istvan Tibor Toth

Gyula Papp

Vera Gergely

Laszlo Szekeres

Jozsef Gaal

Sandor Antus

Istvan Tomoskozi

Agnes Gottsegen

Gyorgy Somogyi

Jozsef Lengyel

Karoly Kanai

Geza Galambos

Zoltan Ecsery

Gyorgy Dorman

Katalin Kaloy

Pal Hadhazy

Emil Minker

Jozsef Nemes

Peter Gyory

Laszlo Harsing

Lorand Debreczeni

Katalin Kalloy

Peter Sarkozi

Zoltan Vargai

Andrea Gerloczy

Eva Udvary

Walter Birkmayer

Csaba Szantai

Eniko Schreiner Nee Kovats

Szilveszter Vizi

Andrea Bolehovszky

Laszo Tardos

Lelle Vasvari (nee Debreczy)

Erzsebet Babos Nee Vajas

Katalin Marmarosi (nee Kellner)

This invention relates to a primycin-containing colloidal basic gel comprising 5-30% of primycin and 95-70% of N-methyl-pyrrolidone-2. The invention also relates to antibacterial compositions particularly for the treatment of acne vulgaris comprising as active ingredient 0.1-100% of a primycin-containing colloidal basic gel, if desired together with further antimicrobial active ingredients, in admixture with 99.9-0% of usual inert pharmaceutical filling, diluting and other formulating additives. The invention also relates to combination composition comprising as active ingredient 1-60% of a primycin-containing colloidal basic gel and 0.1-40% of further pharmaceutical active ingredient(s), e.g. one or more antibiotic(s), chemotherapeutical agent(s), fungistatic or fungicidal agent(s), steroidal or non-steroidal antiinflammatory agent (s), epithelogenic agent(s), local anaesthetic(s), and/or vitamin(s).

Primycin-containing colloidal basic gel

The invention relates to a synergistic pharmaceutical composition, which comprises as an active ingredient a combination of 1-phenylalanine and (-)-deprenyl [(-)-N-(1-phenylisopropyl)-N-methyl-N-propinylamine hydrochloride] and optionally carbidopa [3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propionic acid monohydrate] or benzerazide [N-(DL-seryl)-N'-( 2,3,4-trihydroxybenzyl)-hydrazine] in association with conventional inert, non-toxic solid or liquid pharamaceutical carriers. The invention further relates to the preparation of these compositions and to the use thereof for the treatment of depressive symptoms.

Synergistic pharmaceutical compositions, their production and use

The invention relates to novel racemic or optically active berban derivatives of the formula (I) ##STR1## wherein R.sup.1 and R.sup.2 represent independently from the other a hydroxyl, straight or branched chain alkoxy group 1 to 6 carbon atoms or R.sup.1 and R.sup.2 together represent a C.sub.1-3 alkylenedioxy group;

Berban derivatives as .alpha..sub.2 -adrenergic antagonists

The invention relates to new oxidiazole-alkyl-purine-derivatives of the Formula I ##STR1## and pharmaceutically acceptable salts thereof wherein A stands for C.sub.1-4 alkylene and

Oxadiazole-alkyl-purine derivatives useful as antitussive agents

A new method of treatment is disclosed for a vascular obstructive lesion resulting from restricted blood circulation, characterized by an erythrocyte pathology, in an effected animal subject. The new method involves the administration of 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium-theophylli ne-7-acetat e, in a dosage and at a rate sufficient to maintain a blood concentration of at least 0.5 to at most 3 .gamma./ml, calculated on the basis of 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinoline.

Method of treating a vascular obstructive lesion resulting from

The invention relates to a method of promoting the fat digestion and absorption, which comprises orally administering to an animal subject a partially methylated-.beta.-cyclodextrin optionally together with pharmaceutically acceptable auxiliary and/or additive materials.

Bile-substituting method of treatment for the promotion of fat digestion

The invention relates to new 7-oxo-PGI.sub.2 -ephedrine salt analogues of the Formula I ##STR1## wherein A stands for --(CH.sub.2).sub.2 --, cis or trans --CH.dbd.CH-- or --C.tbd.C--;

7-oxo-PGI.sub.2 -ephedrine salts and their pharmaceutical compositions

Growing community of inventors

Budapest, Hungary

Jeno Marton